Funds and ETFs LeMaitre Vascular, Inc.

Equities

LMAT

US5255582018

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-04-30 pm EDT 5-day change 1st Jan Change
64.8 USD -2.17% Intraday chart for LeMaitre Vascular, Inc. +0.89% +14.16%
LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Its portfolio of product lines is primarily used to treat vascular disease, of which most are used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy catheters, occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. The Company’s principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. The Company sells its products and services primarily through a direct sales force.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
64.8 USD
Average target price
73.57 USD
Spread / Average Target
+13.54%
Consensus
  1. Stock Market
  2. Equities
  3. LMAT Stock
  4. Funds and ETFs LeMaitre Vascular, Inc.